Optimi Health Corp. OPTH

Company Overview

Optimi Health Corp. is a Canadian biotechnology and wellness company focused on the cultivation, formulation, and supply of psychedelic substances and functional mushroom products for research, therapeutic, and wellness applications. The company operates primarily in the emerging psychedelic pharmaceutical and nutraceutical sectors, with activities centered on psilocybin and MDMA supply, analytical testing, drug formulation, and natural health products. Its business model combines pharmaceutical-grade psychedelic manufacturing with wellness-oriented consumer products, positioning the company within both regulated drug development markets and broader health and wellness categories.

The company’s primary revenue drivers have included the production and sale of functional mushroom formulations, psychedelic research materials, and contract manufacturing or supply arrangements tied to regulated research programs. Optimi Health has emphasized compliance-driven production standards, including Good Manufacturing Practice (GMP)-aligned infrastructure and controlled cultivation environments. Founded in Canada, the company evolved from a wellness and nutraceutical focus into a vertically integrated psychedelic supply platform as regulatory interest in psychedelic-assisted therapy expanded in North America and internationally.